Alexandria Real Estate (NYSE:ARE) is about as successful a Wall Street story as you’ll find. Started in 1994 as what management fondly recalls as a garage startup, the company now is one of the most successful and unique REITs on the market today. What makes the company so special is that Alexandria was the first REIT to focus exclusively on life science and biotechnology clients, specifically in the most prime real estate markets: Boston, San Francisco, New York City, etc.